https://www.zacks.com/stock/news/2320761/what-s-in-store-for-cardinal-health-cah-in-q4-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2320761
Aug 12, 2024 - Cardinal Health's (CAH) fourth-quarter fiscal 2024 results are expected to reflect solid performance in the Pharmaceutical and Specialty Solutions segment.
zc:-8145526637335791429
0
https://www.zacks.com/stock/news/2319888/seeking-clues-to-cardinal-cah-q4-earnings-a-peek-into-wall-street-projections-for-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2319888
Aug 09, 2024 - Beyond analysts' top -and-bottom-line estimates for Cardinal (CAH), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2024.
zc:7794085632543017595
0
https://www.zacks.com/stock/news/2319519/the-joint-corp-jynt-reports-q2-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2319519
Aug 08, 2024 - The Joint (JYNT) delivered earnings and revenue surprises of -500% and 2.06%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
zc:-7715094624084302204
0
https://www.zacks.com/stock/news/2314695/merit-medical-mmsi-q2-earnings-and-revenues-beat-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2314695
Aug 01, 2024 - Merit Medical (MMSI) delivered earnings and revenue surprises of 4.55% and 0.92%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
zc:2643801076092367972
0
https://www.zacks.com/stock/news/2309934/why-cardinal-health-cah-is-a-top-value-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_value_score-2309934
Jul 26, 2024 - Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
zc:8022937742604241322
0
https://www.zacks.com/stock/news/2308364/cardinal-health-cah-rises-as-market-takes-a-dip-key-facts?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v2-2308364
Jul 24, 2024 - In the most recent trading session, Cardinal Health (CAH) closed at $96.71, indicating a +0.91% shift from the previous trading day.
zc:5298977219800701350
0
https://www.zacks.com/stock/news/2301066/reasons-to-retain-cardinal-health-cah-in-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2301066
Jul 12, 2024 - Cardinal Health (CAH) gains from a solid pharmaceutical segment and a diversified product portfolio. However, regulatory setbacks are a concern.
zc:-1161192293561550012
0
https://www.zacks.com/stock/news/2299224/are-you-a-value-investor-this-1-stock-could-be-the-perfect-pick?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_value_score-2299224
Jul 10, 2024 - Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
zc:-4776875251543492109
0
https://www.zacks.com/stock/news/2298834/cardinal-health-cah-stock-declines-while-market-improves-some-information-for-investors?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v3-2298834
Jul 09, 2024 - Cardinal Health (CAH) concluded the recent trading session at $96.01, signifying a -0.9% move from its prior day's close.
zc:3724046594934265748
0
https://www.zacks.com/stock/news/2280103/reasons-to-retain-cardinal-health-cah-in-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2280103
May 28, 2024 - Cardinal Health (CAH) gains from a solid pharmaceutical segment and a diversified product portfolio. Gross margins improve. However, the rising cost of products is a concern.
zc:2209559399712752502
0